Esophageal Cancer,Gastrointestinal Cancer Durvalumab and FLOT in Resectable GC/GEJC: MATTERHORN Jan 19, 2024
Gastrointestinal Cancer,Gynecologic Cancer,Ovarian Cancer,Pancreatic Cancer HuCART-Meso and VCN-01 Combo in Pancreatic & Ovarian Cancer Jan 19, 2024
Gastrointestinal Cancer,Liver Cancer Atezolizumab+Bevacizumab: Etiological Influence on HCC Outcomes Jan 17, 2024
Colorectal Cancer,Gastrointestinal Cancer Efficacy of Lenvatinib + Pembrolizumab in mCRC Jan 15, 2024
Gastrointestinal Cancer,Head & Neck Cancer,Pancreatic Cancer LYT-200/Tislelizumab Shows Efficacy in R/R Cancers Jan 11, 2024
Colorectal Cancer,Gastrointestinal Cancer Fruquintinib Alone vs. Combo With ICIs in MSS mCRC Jan 05, 2024
Gastrointestinal Cancer,Liver Cancer EUS-FNB Unlocks Aggressive Pancreatic Subclone for Targeted Therapy Jan 04, 2024
Colorectal Cancer,Gastrointestinal Cancer Neoadjuvant Nivolumab/Relatlimab in dMMR Colon Cancer Dec 26, 2023
